Log in
Enquire now
‌

US Patent 9259424 Concentrated, inhalable antibiotic formulation

Patent 9259424 was granted and assigned to aradigm corporation on February, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
aradigm corporation
0
Current Assignee
‌
aradigm corporation
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
92594240
Patent Inventor Names
David C. Cipolla0
James Blanchard0
Date of Patent
February 16, 2016
0
Patent Application Number
145528170
Date Filed
November 25, 2014
0
Patent Citations Received
‌
US Patent 12016873 Methods for treating pulmonary non-tuberculous mycobacterial infections
0
Patent Primary Examiner
‌
Scott Long
0
Patent abstract

A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9259424 Concentrated, inhalable antibiotic formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.